Validity of Diagnostic Codes and Prevalence of Physician-Diagnosed Psoriasis and Psoriatic Arthritis in Southern Sweden – A Population-Based Register Study
Open Access
- 29 May 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (5) , e98024
Abstract
To validate diagnostic codes for psoriasis and psoriatic arthritis (PsA) and estimate physician-diagnosed prevalence of psoriasis and PsA in the Skåne region, Sweden. In the Skåne Healthcare Register (SHR), all healthcare consultations are continuously collected for all inhabitants in the Skåne region (population 1.2 million). During 2005–2010 we identified individuals with ≥1 physician-consultations consistent with psoriasis (ICD-10). Within this group we also identified those diagnosed with PsA. We performed a validation by reviewing medical records in 100 randomly selected cases for psoriasis and psoriasis with PsA, respectively. Further, we estimated the pre- and post-validation point prevalence by December 31, 2010. We identified 16 171 individuals (psoriasis alone: n = 13 185, psoriasis with PsA n = 2 986). The proportion of ICD-10 codes that could be confirmed by review of medical records was 81% for psoriasis and 63% for psoriasis with PsA with highest percentage of confirmed codes for cases diagnosed ≥2 occasions in specialized care. For 19% and 29% of the cases respectively it was not possible to determine diagnosis due to insufficient information. Thus, the positive predicted value (PPV) of one ICD-10 code for psoriasis and psoriasis with PsA ranged between 81–100% and 63–92%, respectively. Assuming the most conservative PPV, the post-validation prevalence was 1.23% (95% CI: 1.21–1.25) for psoriasis (with or without PsA), 1.02% (95% CI: 1.00–1.03) for psoriasis alone and 0.21% (95% CI: 0.20–0.22) for psoriasis with PsA. The post-validation prevalence of PsA in the psoriasis cohort was 17.3% (95% CI: 16.65–17.96). The proportion of diagnostic codes in SHR that could be verified varied with frequency of diagnostic codes and level of care highlighting the importance of sensitivity analyses using different case ascertainment criteria. The prevalence of physician-diagnosed psoriasis and PsA confirm other population-based studies, also after adjustment due to misclassification of disease.Keywords
This publication has 37 references indexed in Scilit:
- Validation of Psoriatic Arthritis Diagnoses in Electronic Medical Records Using Natural Language ProcessingSeminars in Arthritis and Rheumatism, 2011
- Economic burden of comorbidities in patients with psoriasis is substantialJournal of the European Academy of Dermatology and Venereology, 2011
- Validity of The Health Improvement Network (THIN) for the study of psoriasisBritish Journal of Dermatology, 2010
- Cost of Illness from the Public Payers’ Perspective in Patients with Ankylosing Spondylitis in Rheumatological CareThe Journal of Rheumatology, 2010
- Time Trends in Epidemiology and Characteristics of Psoriatic Arthritis Over 3 Decades: A Population-based StudyThe Journal of Rheumatology, 2009
- Epidemiological and clinical characteristics of psoriatic arthritis in northern NorwayScandinavian Journal of Rheumatology, 2009
- Potential misclassification of patients with psoriasis in electronic databasesJournal of the American Academy of Dermatology, 2008
- The occurrence of psoriatic arthritis in DenmarkAnnals of the Rheumatic Diseases, 2008
- Prevalence and Treatment of Psoriasis in the United KingdomArchives of Dermatology, 2005
- Epidemiology of psoriatic arthritis in the population of the United StatesJournal of the American Academy of Dermatology, 2005